All Products
Cartalax Peptide — 20mg
Cartalax is a synthetic research tripeptide with the amino-acid sequence Ala–Glu–Asp (AED). This listing provides 20mg nominal content in one research vial. Published laboratory studies examine AED in cartilage-cell, stem-cell and fibroblast models, including gene expression and cellular senescence. Not for human or veterinary use.
View batch documentationCartalax peptide identity and specifications
Cartalax is associated with the synthetic tripeptide Ala–Glu–Asp. Its three residues are alanine, glutamic acid and aspartic acid. The one-letter sequence AED is useful for identifying the peptide in research literature and laboratory records.
| Compound | Cartalax |
|---|---|
| Peptide class | Synthetic tripeptide |
| Sequence | Ala–Glu–Asp (AED) |
| Nominal content | 20mg per vial |
| Sale unit | One research vial |
| Intended use | Laboratory research only |
Cartalax and cartilage-cell research
A 2023 laboratory study examined AED in chondrocytes, the cells that produce and maintain cartilage matrix. The researchers assessed proteins and inflammatory signals associated with cellular senescence.
A separate stem-cell study investigated AED alongside markers of cartilage-related differentiation and gene expression, including SOX9, aggrecan, type II collagen and COMP. These findings describe experimental systems and do not establish a clinical treatment effect.
AED in comparative cell studies
Research comparing AED and KE peptides in cultured human skin fibroblasts examined collagen, sirtuins and inflammatory signaling proteins during replicative aging. This helps place Cartalax within the literature on short-peptide cell signaling.
The references below concern the peptide studied in those experiments. They do not certify the identity, purity or measured content of the vial offered here. The 20mg listing is nominal formulation content.
Frequently asked questions
What is the difference between Cartalax and AED?
Cartalax is a name associated with the Ala–Glu–Asp tripeptide. AED is the one-letter abbreviation of the same amino-acid sequence.
How many amino acids are in Cartalax?
Cartalax contains three amino-acid residues: alanine, glutamic acid and aspartic acid. It is therefore a tripeptide.
What does the 20mg specification mean?
It is the nominal Cartalax content per vial. It is not a solution concentration or an independently measured result for this stock.
Is this a single vial or a ten-vial kit?
This listing is sold by the individual vial. Quantity one contains one nominal 20mg Cartalax research vial.
Research references
- Cartalax chemical identity — PubChem (opens in a new tab)
- AED and chondrocyte senescence markers — 2023 study (opens in a new tab)
- AED and cartilage-related gene expression in stem cells — 2023 study (opens in a new tab)
- Comparison of AED and KE in cultured skin fibroblasts — 2020 study (opens in a new tab)
Related research materials
PRODUCT & LOT INFORMATION
Product documentation
Amounts are nominal formulation content, not independently measured results for this stock. No lot-specific certificate of analysis is currently linked to this listing. For laboratory research only; not for human or veterinary use.
CONTINUE EXPLORING
Related research products.
In stockTesamorelin 10mg
In stockSermorelin 10mg
In stockCJC-1295 with DAC 10mg
In stock